Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Jaffe Website

Elaine S. Jaffe, M.D.

Selected Publications

1)  Jaffe ES.
Follicular lymphomas: a tapestry of common and contrasting threads.
Haematologica. 98: 1163-5, 2013.
2)  Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adelaïde J, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B.
Early lesions of follicular lymphoma: a genetic perspective.
Haematologica. 2013.
3)  Nicolae A, Pittaluga S, Venkataraman G, Vijnovich-Baron A, Xi L, Raffeld M, Jaffe ES.
Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
Am. J. Surg. Pathol. 37: 816-26, 2013.
4)  Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, Wang HY, Cheng JX, Bacon CM, Delabie J, Ranheim E, Kucuk C, Hu X, Weisenburger DD, Jaffe ES, Chan WC.
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.
Blood. 2013.
5)  Venkataraman G, Song JY, Tzankov A, Dirnhofer S, Heinze G, Kohl M, Traverse-Glehen A, Eberle FC, Hanson JC, Raffeld MA, Pittaluga S, Jaffe ES.
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival.
Blood. 121: 1795-804, 2013.
6)  Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES.
Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.
Am. J. Surg. Pathol. 37: 333-43, 2013.
7)  Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES.
Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.
Haematologica. 96: 558-66, 2011.
8)  Eberle FC, Salaverria I, Steidl C, Summers TA, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES.
Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.
Mod Pathol. [Epub ahead of print], 2011.
9)  Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, Jaffe ES.
Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma.
Blood. [Epub ahead of print], 2011.
10)  Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES.
Age related EBV associated lymphoproliferative disorder - a spectrum of reactive lymphoid hyperplasia and lymphoma: the Western experience.
Blood. [Epub ahead of print], 2011.
11)  Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES.
NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathological features and follow-up in a unique case series.
Blood. 2010.
12)  Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S.
A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?.
Histopathology. 2013.
13)  Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W, Smith LM, Bi C, Jiang C, Greiner TC, Weisenburger DD, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Gascoyne RD, Cook JR, Tubbs RR, Jaffe ES, Armitage JO, Vose JM, Staudt LM, McKeithan TW, Chan WC, Ye BH, Fu K.
Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
J. Clin. Oncol. 2013.
14)  Valera A, Colomo L, Martínez A, de Jong D, Balagué O, Matheu G, Martínez M, Taddesse-Heath L, Jaffe ES, Bacchi CE, Campo E.
ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.
Mod. Pathol. 2013.
15)  Huppmann AR, Roullet MR, Raffeld M, Jaffe ES.
Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation.
J. Clin. Oncol. 31: e28-30, 2013.
16)  Mirsaeidi M, Syed F, Jaffe ES.
Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitis Is Associated with Epstein - Barr virus in the Setting of HIV Infection.
Infect Dis Clin Pract (Baltim Md). 21: 50-53, 2013.
17)  Salaverria I, Royo C, Carvajal-Cuenca A, Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G, Klapper W, Hartmann EM, Sujobert P, Wlodarska I, Ferry JA, Gaulard P, Ott G, Rosenwald A, Lopez-Guillermo A, Quintanilla-Martinez L, Harris NL, Jaffe ES, Siebert R, Campo E, Beà S.
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
Blood. 121: 1394-402, 2013.
18)  Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage KJ, Weisenburger DD, Armitage JO, Mounier N, Vose JM.
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
J. Clin. Oncol. 31: 240-6, 2013.
19)  Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH.
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
N. Engl. J. Med. 368: 1408-16, 2013.
20)  Vo P, Jaffe ES, Cook L, Ramos C, Childs R.
Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.
Clin Lymphoma Myeloma Leuk. 13: e1-5, 2013.
21)  Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W, Kucuk C, Rinaldi A, Bertoni F, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, Dave BJ, Gascoyne RD, Rosenwald A, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Staudt LM, Chan WC.
Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
Blood. 2013.
22)  Enjuanes A, Albero R, Clot G, Navarro A, Beà S, Pinyol M, Martín-Subero JI, Klapper W, Staudt LM, Jaffe ES, Rimsza L, Braziel RM, Delabie J, Cook JR, Tubbs RR, Gascoyne R, Connors JM, Weisenburger DD, Greiner TC, Chan WC, López-Guillermo A, Rosenwald A, Ott G, Campo E, Jares P.
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.
Int. J. Cancer. 2013.
23)  Goldenberg DM, Gold DV, Loo M, Liu D, Chang CH, Jaffe ES.
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.
PLoS ONE. 8: e55324, 2013.
24)  Aung PP, Climent F, Muzzafar T, Curry JL, Patel KP, Servitje O, Prieto VG, Duvic M, Jaffe ES, Torres-Cabala CA.
Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
J. Cutan. Pathol. 2013.
25)  Liu Q, Pittaluga S, Davies-Hill T, Raffeld M, Xi L, Jaffe ES.
Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall.
Histopathology. 63: 877-80, 2013.
26)  Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH.
Low-intensity therapy in adults with Burkitt"s lymphoma.
N. Engl. J. Med. 369: 1915-25, 2013.
27)  Bajor-Dattilo EB, Pittaluga S, Jaffe ES.
Pathobiology of T-cell and NK-cell lymphomas.
Best Pract Res Clin Haematol. 26: 75-87, 2013.
28)  Attygalle AD, Cabeçadas J, Gaulard P, Jaffe ES, de Jong D, Ko YH, Said J, Klapper W.
Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
Histopathology. 2013.
29)  Jaffe ES, Nicolae A, Pittaluga S.
Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls.
Mod. Pathol. 26 Suppl 1: S71-87, 2013.
30)  Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, Ranuncolo SM, Zhao H, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Shaham S, Staudt LM.
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.
Proc. Natl. Acad. Sci. U.S.A. 110: 3943-8, 2013.
31)  Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES.
Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential.
Pediatr Blood Cancer. 60: 1165-70, 2013.
32)  Menon MP, Hutchinson L, Garver J, Jaffe ES, Woda BA.
Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma.
J. Clin. Oncol. 31: e53-6, 2013.
33)  Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, Cook JR, Staudt LM, Connors JM, Sehn LH, Vose JM, López-Guillermo A, Campo E, Chan WC, Weisenburger DD.
A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
Blood. [Epub ahead of print], 2012.
34)  Mehta N, Wayne AS, Kim YH, Hale GA, Alvarado CS, Myskowski P, Jaffe ES, Busam KJ, Pulitzer M, Zwerner J, Horwitz S.
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.
Clin Lymphoma Myeloma Leuk. 12: 20-5, 2012.
35)  Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM.
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
Nature. 490: 116-20, 2012.
36)  Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, Rimsza LM, Valentino C, Brunhoeber P, Grogan TM, Braziel RM, Cook JR, Tubbs RR, Weisenburger DD, Campo E, Rosenwald A, Ott G, Delabie J, Holcroft C, Jaffe ES, Staudt LM, Gascoyne RD.
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
J. Clin. Oncol. [Epub ahead of print], 2012.
37)  Iqbal J, Shen Y, Liu Y, Fu K, Jaffe ES, Liu C, Liu Z, Lachel CM, Deffenbacher K, Greiner TC, Vose JM, Bhagavathi S, Staudt LM, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, McKeithan TW, Chan WC.
Genome-wide MicroRNA profiling of mantle cell lymphoma reveal a distinct subgroup with poor prognosis.
Blood. [Epub ahead of print], 2012.
38)  Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH.
Gray Zone Lymphoma: Better Treated Like Hodgkin Lymphoma or Mediastinal Large B-Cell Lymphoma?.
Curr Hematol Malig Rep. 7: 241-7, 2012.
39)  Ranuncolo SM, Pittaluga S, Evbuomwan MO, Jaffe ES, Lewis BA.
Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival.
Blood. 120: 3756-63, 2012.
40)  Schiffenbauer AI, Wahl C, Pittaluga S, Jaffe ES, Hoffman R, Khosroshahi A, Stone JH, Deshpande V, Gahl WA, Gill F.
IgG4-related disease presenting as recurrent mastoiditis.
Laryngoscope. 122: 681-4, 2012.
41)  Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E.
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
Haematologica. 97: 270-8, 2012.
42)  Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR.
MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response.
Haematologica. 97: 586-94, 2012.
43)  Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES.
Nodal Involvement by Cutaneous CD30-positive T-cell Lymphoma Mimicking Classical Hodgkin Lymphoma.
Am. J. Surg. Pathol. 36: 716-25, 2012.
44)  Petrini P, French CA, Rajan A, Cameron MJ, Jaffe ES, Zucali PA, Xie J, Wang Y, Giaccone G.
NUT rearrangement is uncommon in human thymic epithelial tumors.
J Thorac Oncol. 7: 744-50, 2012.
45)  Menon MP, Pittaluga S, Jaffe ES.
The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.
Cancer J. 18: 411-20, 2012.
46)  Mitrovic Z, Perry AM, Suzumiya J, Armitage JO, Au WY, Coiffier B, Holte H, Jaffe ES, Monserrat E, Rajan SK, Savage KJ, Tobinai K, Vose JM, Weisenburger DD.
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymphoma Project.
Am J Hematol. [Epub ahead of print], 2012.
47)  Jaffe ES, Pittaluga S.
Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.
Hematology Am Soc Hematol Educ Program. 2011: 506-14, 2011.
48)  Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES.
CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma.
Histopathology. 58: 803-5, 2011.
49)  Jaffe ES.
Centralized Review Offers Promise for the Clinician, the Pathologist, and the Patient With Newly Diagnosed Lymphoma.
J Clin Oncol. [Epub ahead of print], 2011.
50)  Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk S, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE.
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28 year experience in the United States.
Blood. [Epub ahead of print], 2011.
51)  Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES.
Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
Mod Pathol. [Epub ahead of print], 2011.
52)  Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES.
Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.
Am. J. Surg. Pathol. 35: 767-72, 2011.
53)  Vela-Chávez T, Adam P, Kremer M, Bink K, Bacon CM, Menon G, Ferry JA, Fend F, Jaffe ES, Quintanilla-Martínez L.
Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus.
Leuk. Lymphoma. 52: 458-66, 2011.
54)  Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, Connors JM, Rimsza L, Harris NL, Müller-Hermelink K, Rüdiger T, Coiffier B, Gascoyne RD, Berger F, Tobinai K, Au WY, Liang R, Montserrat E, Hochberg EP, Pileri S, Federico M, Nathwani B, Armitage JO, Weisenburger DD.
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project.
Blood. 118: 148-55, 2011.
55)  Summers TA, Jaffe ES.
Hairy cell leukemia diagnostic criteria and differential diagnosis.
Leuk Lymphoma. [Epub ahead of print], 2011.
56)  Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, González-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, Rimsza L, Braziel R, Rosenwald A, Lenz G, Wright G, Jaffe ES, Staudt L, Jares P, López-Guillermo A, Campo E.
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.
Haematologica. 96: 996-1001, 2011.
57)  da Silva SP, Resnick E, Lucas M, Lortan J, Patel S, Cunningham-Rundles C, Gatter K, Liu Q, Jaffe ES, Chapel H.
Lymphoid Proliferations of Indeterminate Malignant Potential arising in Adults with Common Variable Immunodeficiency Disorders: Unusual Case Studies and Immunohistological Review in the Light of Possible Causative Events.
J Clin Immunol. [Epub ahead of print], 2011.
58)  Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Fitzgibbon J, Staudt LM, Mueller-Hermelink HK, Calaminici M, Campo E, Ott G, Hernández L, Rosenwald A.
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
Blood. 118: 5550-8, 2011.
59)  Sohani AR, Jaffe ES, Harris NL, Ferry JA, Pittaluga S, Hasserjian RP.
Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.
Am. J. Surg. Pathol. 35: 1666-78, 2011.
60)  Garcia-Herrera A, Song JY, Chuang S, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A.
Nonhepatosplenic Gamma-Delta T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation.
Am J Surg Pathol. 35: 1214-1225, 2011.
61)  Song JY, Strom T, Raffeld M, Pittaluga S, Jaffe ES.
Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.
J. Clin. Oncol. 29: e789-91, 2011.
62)  Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, Maclennan KA, Rüdiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim W, Holte H, Federico M, Au WY, Tobinai K, Armitage JO, Vose JM.
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.
Blood. [Epub ahead of print], 2011.
63)  Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH.
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.
Leuk Lymphoma. [Epub ahead of print], 2011.
64)  Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE.
Phase II trial of romidepsin in patients with peripheral T-cell lymphoma.
Blood. [Epub ahead of print], 2011.
65)  Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES.
Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do?.
Curr Hematol Malig Rep. 6: 157-63, 2011.
66)  Maldonado NI, Cabanillas F, Jaffe ES, Raffeld M, Lozada L.
Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
J. Clin. Oncol. 29: e658-60, 2011.
67)  Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES.
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
Blood. [Epub ahead of print], 2011.
68)  Herrinton LJ, Liu L, Abramson O, Jaffe ES.
The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006.
Pharmacoepidemiol Drug Saf. [Epub ahead of print], 2011.
69)  Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP, Winter JN, Flowers CR, Nikcevich DA, Sotomayor EM, McGaughey DS, Jaffe ES, Chong EA, Reynolds CW, Berry DA, Santos CF, Popa MA, McCord AM, Kwak LW.
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.
J. Clin. Oncol. 29: 2787-94, 2011.
70)  Rodriguez-Canales J, Eberle FC, Jaffe ES, Emmert-Buck MR.
Why is it crucial to reintegrate pathology into cancer research?.
Bioessays. 33: 490-8, 2011.
71)  Orlov NV, Chen WW, Eckley DM, Macura TJ, Shamir L, Jaffe ES, Goldberg IG.
Automatic classification of lymphoma images with transform-based global features.
IEEE Trans Inf Technol Biomed. 14: 1003-13, 2010.
72)  Raffeld M, Jaffe ES.
Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue.
Methods Mol. Biol. 588: 271-9, 2010.
73)  Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES.
Blastic plasmacytoid dendritic cell neoplasm in the pediatric population: diagnostic features and clinical implications.
Haematologica. [Epub ahead of print], 2010.
74)  Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM.
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
Nature. 463: 88-92, 2010.
75)  Oschlies I, Burkhardt B, Salaverria I, Rosenwald A, D' Amore ES, Szczepanowski M, Koch K, Hansmann ML, Stein H, Moller P, Reiter A, Zimmermann M, Rosolen A, Siebert R, Jaffe ES, Klapper W.
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.
Haematologica. [Epub ahead of print], 2010.
76)  Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Weisenburger DD, Chan WC, Gascoyne RD, Levens D, Staudt LM.
Cooperative epigenetic modulation by cancer amplicon genes.
Cancer Cell. 18: 590-605, 2010.
77)  Lamant L, Pileri S, Sabattini E, Brugières L, Jaffe ES, Delsol G.
Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases.
Haematologica. 95: 449-55, 2010.
78)  Venkataraman G, McClain KL, Pittaluga S, Rao VK, Jaffe ES.
Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.
Am. J. Surg. Pathol. 34: 589-94, 2010.
79)  Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES.
EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.
Am. J. Surg. Pathol. 34: 405-17, 2010.
80)  Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA, Swerdlow SH.
Follicular lymphomas with plasmacytic differentiation include two subtypes.
Mod. Pathol. 23: 71-9, 2010.
81)  Mani H, Climent F, Colomo L, Pittaluga S, Raffeld M, Jaffe ES.
Gall Bladder and Extrahepatic Bile Duct Lymphomas: Clinicopathological Observations and Biological Implications.
Am J Surg Pathol. [Epub ahead of print], 2010.
82)  Wang Y, Tan XH, DiGiovanna JJ, Lee CC, Stern JB, Raffeld M, Jaffe ES, Kraemer KH.
Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum.
J. Invest. Dermatol. 130: 1188-91, 2010.
83)  Valera A, Balagué O, Colomo L, Martínez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E.
IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.
Am. J. Surg. Pathol. 34: 1686-94, 2010.
84)  Eberle FC, Hanson JC, Killian JK, Wei L, Ylaya K, Hewitt SM, Jaffe ES, Emmert-Buck MR, Rodriguez-Canales J.
Immunoguided Laser Assisted Microdissection Techniques for DNA Methylation Analysis of Archival Tissue Specimens.
J Mol Diagn. 12: 394-401, 2010.
85)  Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES.
Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR.
Mod Pathol. 23: 866-73, 2010.
86)  Venkataraman G, Rizzo KA, Chavez JJ, Streubel B, Raffeld M, Jaffe ES, Pittaluga S.
Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases.
Mod. Pathol. 2010.
87)  Shao H, Xi L, Raffeld M, Pittaluga S, Dunleavy K, Wilson WH, Spector N, Milito C, Morais JC, Jaffe ES.
Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.
Am. J. Surg. Pathol. 34: 1425-35, 2010.
88)  Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM.
Oncogenically active MYD88 mutations in human lymphoma.
Nature. 2010.
89)  Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan W, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink H, Staudt LM, Ott G, Beà S, Rosenwald A.
Pathway discovery in mantle cell lymphoma by integrated analysis of high resolution gene expression and copy number profiling.
Blood. 116: 953-61, 2010.
90)  Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES.
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Mod Pathol. 23: 991-9, 2010.
91)  Bradley KT, Arber DA, Brown MS, Chang CC, Coupland SE, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill MC, McClure SP, Medeiros LJ, Perkins SL, Hussong JW.
Protocol for the examination of specimens from patients with hematopoietic neoplasms of the ocular adnexa.
Arch. Pathol. Lab. Med. 134: 336-40, 2010.
92)  Hussong JW, Arber DA, Bradley KT, Brown MS, Chang CC, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill M, McClure SP, Medeiros LJ, Perkins SL.
Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms.
Arch. Pathol. Lab. Med. 134: e40-7, 2010.
93)  Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT, Rao VK.
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome: report from the 2009 NIH International Workshop.
Blood. [Epub ahead of print], 2010.
94)  Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK.
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome (ALPS).
Blood. [Epub ahead of print], 2010.
95)  Pittaluga S, Jaffe ES.
T-cell/histiocyte-rich large B-cell lymphoma.
Haematologica. 95: 352-6, 2010.
96)  Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH.
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Blood. 115: 3017-24, 2010.
97)  Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD.
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
N. Engl. J. Med. 362: 875-85, 2010.
98)  Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, Liu Z, Gascoyne RD, Rosenwald A, Ott G, Rimsza LM, Campo E, Jaffe ES, Jaye DL, Staudt LM, Chan WC.
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
Clin. Cancer Res. 15: 5494-502, 2009.
99)  Ouansafi I, Bell S, Jaffe ES.
Adrenal Hodgkin lymphoma.
Br. J. Haematol. 148: 341, 2009.
100)  Rimsza LM, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Murphy SP.
CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression.
Haematologica. 94: 596-8, 2009.
101)  Koch R, Jaffe ES, Mensing C, Zeis M, Schmitz N, Sander CA.
Cutaneous gamma/delta T-cell lymphoma.
J Dtsch Dermatol Ges. 7: 1065-7, 2009.
102)  Wilkinson ST, Fernandez DR, Murphy SP, Braziel RM, Campo E, Chan WC, Delabie J, Gascoyne RD, Staudt LM, Jaffe ES, Rosenwald A, Rimsza LM.
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.
Leuk. Lymphoma. 50: 1875-8, 2009.
103)  Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH.
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.
Blood. 113: 6069-76, 2009.
104)  Cohen JI, Kimura H, Nakamura S, Ko Y, Jaffe ES.
Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.
Ann Oncol. 20: 1472-82, 2009.
105)  Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan W, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, Staudt LM, Hartmann EM, Mueller-Hermelink H, Campo E, Ott G, Rosenwald A.
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
Blood. 114: 826-34, 2009.
106)  Chang CC, Zhou X, Taylor JJ, Huang WT, Ren X, Monzon F, Feng Y, Rao PH, Lu XY, Fabio F, Hilsenbeck S, Creighton CJ, Jaffe ES, Lau CC.
Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma.
J Hematol Oncol. 2: 47, 2009.
107)  Eberle FC, Mani H, Jaffe ES.
Histopathology of Hodgkin's Lymphoma.
Cancer J. 15: 129-37, 2009.
108)  Mani H, Jaffe ES.
Hodgkin lymphoma: an update on its biology with new insights into classification.
Clin Lymphoma Myeloma. 9: 206-16, 2009.
109)  Killian JK, Bilke S, Davis S, Walker RL, Killian MS, Jaeger EB, Chen Y, Hipp J, Pittaluga S, Raffeld M, Cornelison R, Smith WI, Bibikova M, Fan JB, Emmert-Buck MR, Jaffe ES, Meltzer PS.
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome.
Cancer Res. 69: 758-64, 2009.
110)  Morovic A, Jaffe ES, Raffeld M, Schrager JA.
Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient.
Am. J. Surg. Pathol. 33: 149-54, 2009.
111)  Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE.
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.
J. Clin. Oncol. 27: 5410-7, 2009.
112)  Jegalian AG, Facchetti F, Jaffe ES.
Plasmacytoid dendritic cells: physiologic roles and pathologic states.
Adv Anat Pathol. 16: 392-404, 2009.
113)  Ritchie D, Piekarz RL, Blombery P, Karai LJ, Pittaluga S, Jaffe ES, Raffeld M, Janik JE, Prince HM, Bates SE.
Reactivation of DNA viruses in association with histone deacetylase inhibitor (HDI) therapy: a case series report.
Haematologica. 94: 1618-22, 2009.
114)  Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE.
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
Blood. 113: 4992-5001, 2009.
115)  Vanan I, Redner A, Atlas M, Marin L, Kadkade P, Bandovic J, Jaffe ES.
Solitary extramedullary plasmacytoma of the vocal cord in an adolescent.
J. Clin. Oncol. 27: e244-7, 2009.
116)  Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne RD, Solé F, López-Guillermo A, Colomer D, Staudt LM, Rosenwald A, Ott G, Jares P, Campo E.
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.
Haematologica. 94: 1555-62, 2009.
117)  Jaffe ES.
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.
Hematology Am Soc Hematol Educ Program. 523-31, 2009.
118)  Swerdlow S, Campo E, Harris NL, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J, eds.
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.
Geneva: WHO Press; 2008. [Book (Editor)]
119)  Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, Camos M, Warnke R, Jaffe ES.
(Plenary Paper) Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.
Blood. 111: 5433-9, 2008.
120)  Rodig SJ, Payne EG, Degar BA, Rollins B, Feldman AL, Jaffe ES, Androkites A, Silverman LB, Longtine JA, Kutok JL, Fleming MD, Aster JC.
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
Am. J. Hematol. 83: 116-21, 2008.
121)  Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne RD, Armitage JO, Weisenburger DD.
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Blood. 111: 5496-504, 2008.
122)  O'Mahony D, Debnath I, Janik J, Aisner D, Jaffe E, Waldmann T, Morris J.
Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience.
Leuk. Lymphoma. 49: 439-46, 2008.
123)  Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Jaffe ES, Staudt LM, Müller-Hermelink HK, Campo E, Rosenwald A.
Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma.
Haematologica. 93: 1327-34, 2008.
124)  Jaffe ES, Harris NL, Stein H, Isaacson PG.
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.
Blood. 112: 4384-99, 2008.
125)  Thieblemont C, Rolland D, Baseggio L, Felman P, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Houlgatte R, Fu K, Weisenburger D, De Jong D, Jaffe ES, Rosenwald A, Ott G, Coiffier B, Berger F.
Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.
Leuk. Lymphoma. 49: 1403-6, 2008.
126)  Martinez A, Pittaluga S, Rudelius M, Davies-Hill T, Sebasigari D, Fountaine TJ, Hewitt S, Jaffe ES, Raffeld M.
Expression of the Interferon Regulatory Factor 8/ICSBP-1 in Human Reactive Lymphoid Tissues and B-cell Lymphomas: A Novel Germinal Center Marker.
Am. J. Surg. Pathol. 2008.
127)  Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A, Shih JH, Jaffe ES.
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.
Blood. 2008.
128)  Nam-Cha SH, San-Millán B, Mollejo M, García-Cosio M, Garijo G, Gomez M, Warnke RA, Jaffe ES, Piris MA.
Light-chain-restricted germinal centres in reactive lymphadenitis: report of eight cases.
Histopathology. 52: 436-44, 2008.
129)  Shanti RM, Torres-Cabala CA, Jaffe ES, Wilson WH, Brahim JS.
Lymphomatoid granulomatosis with involvement of the hard palate: a case report.
J. Oral Maxillofac. Surg. 66: 2161-3, 2008.
130)  Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM.
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
Proc. Natl. Acad. Sci. U.S.A. 105: 13520-5, 2008.
131)  Hwang ST, Janik JE, Jaffe ES, Wilson WH.
Mycosis fungoides and Sezary syndrome.
Lancet. 371: 945-57, 2008.
132)  Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM.
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
Science. 319: 1676-9, 2008.
133)  Wilson WH, Dunleavy K, Pittaluga S, Hegde U, Grant N, Steinberg SM, Raffeld M, Gutierrez M, Chabner BA, Staudt L, Jaffe ES, Janik JE.
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.
J. Clin. Oncol. 26: 2717-24, 2008.
134)  Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM.
Stromal gene signatures in large-B-cell lymphomas.
N. Engl. J. Med. 359: 2313-23, 2008.
135)  Young KH, Leroy K, Moller MB, Colleoni GW, Sanchez-Beato M, Kerbauy FR, Haioun C, Eickhoff JC, Young AH, Gaulard P, Piris MA, Oberley TD, Rehrauer WM, Kahl BS, Malter JS, Campo E, Delabie J, Gascoyne RD, Rosenwald A, Rimsza L, Huang J, Braziel RM, Jaffe ES, Wilson WH, Staudt LM, Vose JM, Chan WC, Weisenburger DD, Greiner TC.
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
Blood. 2008.
136)  Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM.
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.
J. Exp. Med. 204: 633-43, 2007.
137)  Dunleavy K, Wilson WH, Jaffe ES.
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.
Curr. Opin. Hematol. 14: 348-53, 2007.
138)  Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, Wright G, Sanger WG, Pickering DL, Jain S, Horsman DE, Shen Y, Fu K, Weisenburger DD, Hans CP, Campo E, Gascoyne RD, Rosenwald A, Jaffe ES, Delabie J, Rimsza L, Ott G, Müller-Hermelink HK, Connors JM, Vose JM, McKeithan T, Staudt LM, Chan WC.
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.
Leukemia. 2007.
139)  Nava VE, Cohen P, Bishop M, Fowler D, Jaffe ES, Ozdemirli M.
Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma.
Am. J. Surg. Pathol. 31: 476-80, 2007.
140)  Kimm LR, deLeeuw RJ, Savage KJ, Rosenwald A, Campo E, Delabie J, Ott G, Muller-Hermelink HK, Jaffe ES, Rimsza LM, Weisenburger DD, Chan WC, Staudt LM, Connors JM, Gascoyne RD, Lam WL.
Frequent occurrence of deletions in primary mediastinal B-cell lymphoma.
Genes Chromosomes Cancer. 46: 1090-7, 2007.
141)  Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, Rodríguez J, Zajac M, Benitez J, Staudt LM, Martinez-Delgado B.
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas.
J. Clin. Oncol. 25: 3321-9, 2007.
142)  Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Müller-Hermelink HK, Ott G, Fend F, Rosenwald A.
IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Am. J. Surg. Pathol. 31: 1605-14, 2007.
143)  Young KH, Weisenburger DD, Dave BJ, Smith L, Sanger W, Iqbal J, Campo E, Delabie J, Gascoyne RD, Ott G, Rimsza L, Müller-Hermelink HK, Jaffe ES, Rosenwald A, Staudt LM, Chan WC, Greiner TC.
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma.
Blood. 110: 4396-405, 2007.
144)  Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM.
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Blood. 109: 4599-606, 2007.
145)  Kurup SK, Levy-Clarke G, Calvo KR, Jaffe ES, Nussenblatt RB, Chan CC.
Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids.
Clin. Experiment. Ophthalmol. 35: 468-72, 2007.
146)  Hisada M, Chen BE, Jaffe ES, Travis LB.
Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
J. Natl. Cancer Inst. 99: 215-22, 2007.
147)  Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E.
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
J. Clin. Oncol. 25: 1216-22, 2007.
148)  Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, Norton AJ, Goff LK, Fitzgibbon J, Staudt LM, Andrew Lister T.
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.
Br. J. Haematol. 136: 286-93, 2007.
149)  Srinivasan R, Daniels J, Fusaro V, Lundqvist A, Killian JK, Geho D, Quezado M, Kleiner D, Rucker S, Espina V, Whiteley G, Liotta L, Petricoin E, Pittaluga S, Hitt B, Barrett AJ, Rosenblatt K, Childs RW.
Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.
Exp. Hematol. 34: 796-801, 2006.
150)  Vega F, Chang CC, Schwartz MR, Preti HA, Younes M, Ewton A, Verm R, Jaffe ES.
Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease.
Am. J. Surg. Pathol. 30: 539-44, 2006.
151)  Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, Jaffe ES, Grogan TM, Connors JM, Vose JM, Armitage JO, Staudt LM, Chan WC.
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
J. Clin. Oncol. 24: 961-8, 2006.
152)  Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES, Quintanilla-Martinez L, Raffeld M.
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.
Blood. 108: 1668-1676, 2006.
153)  Rao VK, Carrasquillo JA, Dale JK, Bacharach SL, Whatley M, Dugan F, Tretler J, Fleisher T, Puck JM, Wilson W, Jaffe ES, Avila N, Chen CC, Straus SE.
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
Am. J. Hematol. 81: 81-5, 2006.
154)  Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA.
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.
Blood. 108: 3786-3791, 2006.
155)  Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S.
IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
Am. J. Surg. Pathol. 30: 585-92, 2006.
156)  Rimsza LM, Roberts RA, Campo E, Grogan TM, Bea S, Salaverria I, Zettl A, Rosenwald A, Ott G, Muller-Hermelink HK, Delabie J, Fisher RI, Unger JM, Leblanc M, Staudt LM, Jaffe ES, Gascoyne RD, Chan WC, Weisenburger DD, Greiner T, Braziel RM, Miller TP.
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.
Blood. 107: 1101-7, 2006.
157)  Kobrin C, Cha SC, Qin H, Raffeld M, Fend F, Quintanilla-Martinez L, Grove S, Jaffe ES, Kwak LW.
Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: Implications for lymphomagenesis.
Leuk. Lymphoma. 47: 1523-34, 2006.
158)  Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM.
Molecular diagnosis of Burkitt's lymphoma.
N. Engl. J. Med. 354: 2431-42, 2006.
159)  Fountaine TJ, Wincovitch SM, Geho DH, Garfield SH, Pittaluga S.
Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots.
Mod. Pathol. 19: 1181-91, 2006.
160)  Greiner TC, Dasgupta C, Ho VV, Weisenburger DD, Smith LM, Lynch JC, Vose JM, Fu K, Armitage JO, Braziel RM, Campo E, Delabie J, Gascoyne RD, Jaffe ES, Muller-Hermelink HK, Ott G, Rosenwald A, Staudt LM, Im MY, Karaman MW, Pike BL, Chan WC, Hacia JG.
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Proc. Natl. Acad. Sci. U.S.A. 103: 2352-7, 2006.
161)  Quintanilla-Martinez L, Pittaluga S, Miething C, Klier M, Rudelius M, Davies-Hill T, Anastasov N, Martinez A, Vivero A, Duyster J, Jaffe ES, Fend F, Raffeld M.
NPM-ALK dependent expression of the Transcription Factor CCAAT/enhancer binding protein (C/EBP){beta} in Alk-positive Anaplastic Large cell Lymphomas.
Blood. 108: 2029-2036, 2006.
162)  Jaffe ES.
Pathobiology of peripheral T-cell lymphomas.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 317-22, 2006.
163)  Ma CS, Pittaluga S, Avery DT, Hare NJ, Maric I, Klion AD, Nichols KE, Tangye SG.
Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease.
J. Clin. Invest. 116: 322-33, 2006.
164)  Feldman AL, Berthold F, Arceci RJ, Abramowsky C, Shehata BM, Mann KP, Lauer SJ, Pritchard J, Raffeld M, Jaffe ES.
Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis.
Lancet Oncol. 6: 435-7, 2005.
165)  Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC, Lymphoma/Leukemia Molecular Profiling Project .
Cyclin D1-negative mantle cell lymphoma: a clinicopathological study based on gene expression profiling.
Blood. 2005.
166)  Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Powell J, Wilson WH, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Campo E, Rosenwald A.
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
Blood. 106: 3183-90, 2005.
167)  Ahmad E, Kingma DW, Jaffe ES, Schrager JA, Janik J, Wilson W, Stetler-Stevenson M.
Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow.
Cytometry. Part B, Clinical cytometry. 67: 6-12, 2005.
168)  Schrager JA, Pittaluga S, Raffeld M, Jaffe ES.
Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome.
Am J Surg Pathol. 29: 1115-6, 2005.
169)  Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES.
Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
Am J Surg Pathol. 29: 903-11, 2005.
170)  Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, Jaffe ES.
Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Am. J. Surg. Pathol. 29: 1411-21, 2005.
171)  Valiathan M, Rao RV, Rao L, Jaffe ES, Pillai S.
Nasal NK/T cell lymphoma mimicking a squamous cell carcinoma: a case report.
Indian journal of pathology & microbiology. 48: 257-9, 2005.
172)  Neelapu SS, Gause BL, Nikcevich DA, Schuster SJ, Winter J, Gockerman JP, Loughran T, Takeshita K, Inghirami G, McGaughey D, Watson TM, Snow S, Kubovic P, Ferraro M, Jones E, Jaffe ES, Schwartzentruber DJ, Danforth D, Sherry R, Kass E, Van Waes C, Reynolds CW, Kwak LJ.
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.
Clinical lymphoma. 6: 61-4, 2005.
173)  Gulmann C, Espina V, Petricoin E, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL.
Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
Clin Cancer Res. 11: 5847-55, 2005.
174)  Nava VE, Jaffe ES.
The pathology of NK-cell lymphomas and leukemias.
Adv Anat Pathol. 12: 27-34, 2005.
175)  Neelapu SS, Kwak LW, Kobrin CB, Reynolds CW, Janik JE, Dunleavy K, White T, Harvey L, Pennington R, Stetler-Stevenson M, Jaffe ES, Steinberg SM, Gress R, Hakim F, Wilson WH.
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
Nat. Med. 11: 986-91, 2005.
176)  Zu Y, Steinberg SM, Campo E, Hans CP, Weisenburger DD, Braziel RM, Delabie J, Gascoyne RD, Muller-Hermlink K, Pittaluga S, Raffeld M, Chan WC, Jaffe ES, Pathology Panel of the Lymphoma/Leukemia Molecular Profiling Project .
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma.
Leuk Lymphoma. 46: 693-701, 2005.
177)  Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ.
WHO-EORTC classification for cutaneous lymphomas.
Blood. 105: 3768-85, 2005.
178)  Martinez A, Pittaluga S, Villamor N, Colomer D, Rozman M, Raffeld M, Montserrat E, Campo E, Jaffe ES.
Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis.
Am J Surg Pathol. 28: 849-58, 2004.
179)  Jaffe ES.
Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation.
J Natl Cancer Inst. 96: 571-3, 2004.
180)  Colomo L, Loong F, Rives S, Pittaluga S, Martínez A, López-Guillermo A, Ojanguren J, Romagosa V, Jaffe ES, Campo E.
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
Am J Surg Pathol. 28: 736-47, 2004.
181)  Janik JE, Morris JC, Pittaluga S, McDonald K, Raffeld M, Jaffe ES, Grant N, Gutierrez M, Waldmann TA, Wilson WH.
Elevated Serum Soluble Interleukin-2 Receptor Levels in Patients with Anaplastic Large Cell Lymphoma.
Blood. 2004.
182)  Hornick JL, Jaffe ES, Fletcher CD.
Extranodal Histiocytic Sarcoma: Clinicopathologic Analysis of 14 Cases of a Rare Epithelioid Malignancy.
Am J Surg Pathol. 28: 1133-1144, 2004.
183)  Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES.
Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin.
Lancet Oncol. 5: 248-50, 2004.
184)  Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin E, Liotta LA, Jaffe ES.
imilarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.
Lab Invest. 84: 235-244, 2004.
185)  Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, Delabie J, Rosenwald A, Staudt LM, Grogan TM.
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.
Blood. 103: 4251-8, 2004.
186)  Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES.
Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classical Hodgkin’s lymphoma: implications for mediastinal grey zone lymphomas as an intermediate form of B-cell lymphoma.
Adv. Anat. Path. 11: 227-238, 2004.
187)  Kumar S, Pittaluga S, Raffeld M, Guerrera M, Seibel NL, Jaffe ES.
Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
Pediatr Dev Pathol. 8: 52-60, 2004.
188)  Jaffe ES, Banks PM, Nathwani B, Said J, Swerdlow SH.
Recommendations for the reporting of lymphoid neoplasms: A report from the Association of Directors of Anatomic and Surgical Pathology.
Mod Pathol. 17: 131-5, 2004.
189)  Jaffe ES, Krenacs L, Raffeld M.
Classification of cytotoxic T-cell and natural killer cell lymphomas.
Semin Hematol. 40: 175-84, 2003.
190)  Toro JR, Liewehr DJ, Pabby N, Sorbara L, Raffeld M, Steinberg SM, Jaffe ES.
Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma.
Blood. 101: 3407-12, 2003.
191)  Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R, Grogan TM, Fisher RI, Miller TP, LeBlanc M, Chiorazzi M, Zhao H, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Staudt LM.
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
J Exp Med. 198: 851-62, 2003.
192)  Krenacs L, Smyth MJ, Bagdi E, Krenacs T, Kopper L, Rudiger T, Zettl A, Muller-Hermelink HK, Jaffe ES, Raffeld M.
The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity.
Blood. 101: 3590-3, 2003.
193)  Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, Rösen-Wolff A, Peters AM, Sneller MC, Hallahan CW, Wang J, Fischer RE, Jackson CM, Lin AY, Bäumler C, Siegert E, Marx A, Vaishnaw AK, Grodzicky T, Fleisher TA, Lenardo MJ.
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
Blood. 98: 194-200, 2001.
194)  Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC.
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
Blood. 84: 1361-92, 1994.
Click Here to View Collapsed Bibliography.

This page was last updated on 11/20/2013.